The American College of Veterinary Anesthesia and Analgesia was founded in 1975 to promote the advancement of veterinary anesthesiology and to assist the veterinary profession in providing exceptional service to all animals.
The ACVAA is currently composed of over 220 members who practice veterinary anesthesia across the globe.
The goals of the ACVAA include establishing, evaluating and maintaining the highest standards in the practice of veterinary anesthesiology by promoting the establishment of educational facilities and clinical and research training in veterinary anesthesiology. Additionally, the ACVAA establishes the criteria of fitness for the designation of a specialist in the practice of veterinary anesthesiology.
The ACVAA is an AVMA-Recognized Veterinary Specialty Organization. To learn more about specialization in veterinary medicine, see the American Board of Veterinary Specialties of the American Veterinary Medical Association website.
Chronic Pain in Animals Workshop
Wednesday, November 29, 2017
We hope you will plan on attending the upcoming *Chronic Pain in Dogs and Cats Workshop* that will be hosted by NIH on Nov. 29-30, 2017. There is *no *registration cost but everyone does need to register at the website. We want to reach a large audience in hopes of promoting research and analgesic development for companion animals with translational benefit to humans.
Despite advances, chronic pain is one of the most poorly understood and under treated medical problems facing veterinary medicine today. *One of the most frustrating aspects of developing therapeutics for treating chronic pain in veterinary medicine is the **lack of validated methods to measure chronic pain in different species and diseases. **Similarly**, *translational success has often been lacking when taking analgesics from animal models to human clinical trials. Numerous reviews have highlighted a lack of translation of basic research into new approved therapeutics for treating persistent pain in humans. The use of spontaneous painful disease in companion animals is one of the changes that could help improve translation of basic science to new therapeutics to act as a bridge between preclinical and clinical studies. The ultimate goal is to reduce failure rates in human clinical trials with resultant new therapeutics for humans and animals. For this bridge to work, we need *valid outcome measures in animal spontaneous disease conditions and opportunities to share and promote knowledge.*
We are hoping this NIH workshop will bring research, regulatory, academia, and industry together from the veterinary and human arena to tackle these challenges. Find details via the attached link.
Bernadette Dunham, D.V.M., Ph.D George Washington University email@example.com